Sponsor Pipeline

Hua Li Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT05803928
Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies		 overall status: Recruiting → Unknown
Active Trials by Phase
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06900478 Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC Hepatocarcinoma Not Yet Recruiting
Not specified
NCT06232213 Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced… Personalized Cancer Treatment Recruiting
Get alerts when Hua Li's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free